Rolodex›Priya Ravensdale

Priya Ravensdale

SVP Finance · Embercast Bio

London, England, United Kingdom · LinkedIn ↗

Background

SVP Finance at Embercast Bio, an Oxford-based oncology platform spun out of work on tumour microenvironment biology. Previously interim CFO at Tessera Therapeutics UK through their Series A extension, and finance leadership roles at Linden Pharma, Brookmere Bio and Yarrowfield Therapeutics. FCA with a distinction in Fi…

Experience20 yrsCompanies7

Career History

May 2024 – Present2 yr 2 moSVP Finance at Embercast BioLondon, England, United Kingdom

Series A11–50 FTEsOncology · Platform therapeutics

Oxford oncology platform, ~32 FTEs post a £24M Series A; Priya runs finance under a founder-CEO with the CFO seat earmarked but unfilled.

Apr 2023 – Nov 20241 yr 7 moCFO (interim) at Tessera Therapeutics UKLondon, England, United Kingdom

Series A extension18 → 26 FTEs£12M Series A extensionRare disease · Interim CFO

Parachuted in as interim CFO to close a £12M Series A extension and stand up FP&A ahead of a permanent hire.

Sept 2022 – May 20241 yr 8 moSVP Finance at Linden PharmaLondon, England, United Kingdom

Series B22 → 41 FTEs£38M Series BOncology

Joined post-Series A, led the £38M Series B with Sofinnova and built finance from 1 bookkeeper to a 4-person team.

Jul 2019 – Jun 20222 yr 11 moSVP Finance at Brookmere BioLondon, England, United Kingdom

Series A → Acquired9 → 24 FTEs£15M Series A · trade saleTarget-side M&A

Closed £15M Series A then ran target-side diligence through Brookmere's acquisition by a US mid-cap two years later.

Education

FCA — Saltmoor College (1993–1996)

Postgraduate Diploma, Financial Strategy, Distinction — Heathvale University (2016–2017)

Bachelor's degree — Linwood College (1990–1993)